Experiments advance potential of protein that makes hydrogen sulfide as a therapeutic target for Alzheimer’s disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jan-2026 02:11 ET (1-Jan-2026 07:11 GMT/UTC)
Hong Kong, China, December 30, 2025 --- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public in Main Board under Chapter 8.05 listing rules of the HKEX. This initial public offering (IPO) raised a total of HKD 2.277 billion, achieving the largest biotech IPO in Hong Kong this year, as in the size of fundraising.
A research team from City University of Hong Kong (CityUHK) recently collaborated with an international research team to publish a study revealing a correlation between global contamination of per- and polyfluoroalkyl substances (PFAS) in globally consumed edible marine fish and associated human health risks.
The study found that consumers may be exposed to elevated levels of PFAS by consuming imported fish such as salmon, tuna, swordfish and cod — even in regions with low environmental pollution — thereby increasing food‑safety risks.
A research team from City University of Hong Kong (CityUHK) recently collaborated with an international research team to publish a study revealing a correlation between global contamination of per- and polyfluoroalkyl substances (PFAS) in globally consumed edible marine fish and associated human health risks.
The study found that consumers may be exposed to elevated levels of PFAS by consuming imported fish such as salmon, tuna, swordfish and cod — even in regions with low environmental pollution — thereby increasing food‑safety risks.